Novo Nordisk is whacking 400 R&D jobs, reorganizing global R&D ops around 4 “transformational” units
Novo Nordisk rolled out a new plan to revamp its global R&D operations, slashing hundreds of jobs as it sets up new “biotech-like” research units in key hubs aimed at helping them line up new collaborations in key disease fields.
Out: About 400 R&D jobs in established centers in Denmark and China, axing out a significant number of staffers to make way for what Novo is heralding as a drive to heightened innovation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.